Results 211 to 220 of about 19,649 (222)

The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein

Cancer Cell, 2005
Paolo Neviani, Rossana Trotta, Bradley W Blaser   +2 more
exaly  

AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance

Cancer Cell, 2009
Christopher A Eide, Victor M Rivera, Jeffrey W Tyner   +2 more
exaly  

Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

New England Journal of Medicine, 2001
Brian J Druker, Charles L Sawyers, Hagop M Kantarjian   +2 more
exaly  

Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction

Lancet, The, 1991
exaly  

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene

Cell, 1986
Robert Peter Gale
exaly  

Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia

Cell, 1987
Nora Heisterkamp, Dies Meijer, Leanne M Wiedemann   +2 more
exaly  

Nasopharyngeal Carcinoma in Adult Woman with Chronic Myelogenous Leukemia BCR-ABL Positive A Rare Case of Double Primary Malignancy

Kuswanto, Adrian, Agus Jati Sunggoro, Marwanta, Sri, Sihwidhi Dimas Sudarmadi   +3 more
openaire   +1 more source

DETECTION OF RESIDUAL bcr/abl TRANSLOCATION BY POLYMERASE CHAIN REACTION IN CHRONIC MYELOID LEUKAEMIA PATIENTS AFTER BONE-MARROW TRANSPLANTATION

Lancet, The, 1989
exaly  

Ponatinib active in BCR–ABL-positive disease

Nature Reviews Clinical Oncology, 2013
exaly  

Human medicines European public assessment report (EPAR): Sprycel, dasatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma,Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Date of authorisation: 20/11/2006, Revision: 32, Status: Authorised

Case Medical Research, 2019
openaire   +2 more sources